Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Convertible Debt (2016 - 2019)

Historic Convertible Debt for BioCorRx (BICX) over the last 7 years, with Q4 2019 value amounting to $4.2 million.

  • BioCorRx's Convertible Debt changed N/A to $4.2 million in Q4 2019 from the same period last year, while for Dec 2019 it was $4.2 million, marking a year-over-year change of. This contributed to the annual value of $4.2 million for FY2019, which is N/A changed from last year.
  • According to the latest figures from Q4 2019, BioCorRx's Convertible Debt is $4.2 million.
  • In the past 5 years, BioCorRx's Convertible Debt ranged from a high of $4.2 million in Q4 2019 and a low of $685.0 during Q3 2015
  • In the last 5 years, BioCorRx's Convertible Debt had a median value of $688783.0 in 2016 and averaged $1.1 million.
  • Per our database at Business Quant, BioCorRx's Convertible Debt soared by 7315051.09% in 2016 and then surged by 16619.9% in 2018.
  • Over the past 5 years, BioCorRx's Convertible Debt (Quarter) stood at $5530.0 in 2015, then skyrocketed by 12355.39% to $688783.0 in 2016, then soared by 192.7% to $2.0 million in 2017, then rose by 18.2% to $2.4 million in 2018, then surged by 74.58% to $4.2 million in 2019.
  • Its last three reported values are $4.2 million in Q4 2019, $2.4 million for Q1 2018, and $2.0 million during Q4 2017.